HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

515.560

-16.828-3.16%

Number of Gainers:6

Number of Losers:26

Number of Flat:1

PE:- -

High:526.804

Open:526.804

Low:504.120

Close:532.388

Volume:37.26M

Turnover:983.79M

Market Cap:325.98B

Float Cap:291.58B

Loading ...

Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%

Shares of TRANSCENTA-B Surge Over 29% Intraday After Chairman Qian Xueming Increases Stake

Hong Kong Stock Alert | METIS TECHBIO-P (07666) Surges Over 9% Again, AI Drug Development Momentum Builds on Multiple Catalysts — Company's AI Plus Delivery Platform Value Gaining Recognition

Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth

Hong Kong Stock Market Flash | Genscript Biotech Surges Over 7% in Morning Session as AI Drug Discovery Models Reshape Its Business Trajectory

Beyond 2025: How AI Drug Discovery Companies Will Be Priced on Speed, Depth, and Modality Optionality

本周科技板块亮点密集，AI制药成市场新焦点｜港股策略前瞻

Antengene Doses First Patient in Phase III Clinch-3 Trial of ATG-022 for Cldn18.2+ Gastric, GEJ Cancer

GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings

Antengene Announces First Patient Dosed in Pivotal Phase Iii Clinch-3 Study of Atg-022

THOMSON REUTERS

GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18

Australian Drug Maker Telix Strikes $1.65B Deal for Germany's ITM

China Securities: Small-Cap Growth Outperforms While Healthcare Funds Show Strong Weekly Gains

AI-Driven Drug Development Hits a Milestone Phase as New Policies Fuel Momentum—Which ETF Offers the Highest AI Exposure?

H Share Subscription Deal Between TYK Medicines and Qilu Expires

Yan'an Pharma Withdraws Beijing IPO for Second Time, Sees Nearly Doubled Fundraising Target Questioned

From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?

Money Xue Purchases Additional Trancenta Shares at HK$0.8552 Each

BRII-B (02137) Spends HK$25,800 on Share Buyback on September 18

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK1574/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":515.5602,"timestamp":1790928487328,"preClose":532.3884,"halted":0,"volume":37258611,"delay":0,"changeRate":-0.031609,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-16.828247,"latestTime":"10-02 16:00:00","open":526.80365,"high":526.80365,"low":504.12042,"amount":983786061.5,"amplitude":0.042607,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":3.967371,"peRate":176.437057,"turnoverRate":0.001378,"increases":5,"decrements":27,"flats":0,"marketCap":325975381968,"floatMarketCap":291576058040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":526.80365,"amplitude":0.042607,"preClose":532.3884,"low":504.12042,"pbRate":"3.967371","latestPrice":515.5602,"volume":37258611,"delay":0,"open":526.80365,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":495.278,"twentyDayClose":515.473,"sixtyDayClose":490.453,"secType":"PLATE","market":"HK","turnoverRate":0.001378,"peRate":176.437057,"marketCap":325975381968,"floatMarketCap":291576058040,"timestamp":1790928487328,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196765579","title":"Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196765579","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196765579?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:41","pubTimestamp":1789962092,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks experienced a broad rally in early trading, with multiple leading companies posting significant gains. As of the latest update, Keymed Bio-B (02162) jumped 9.09% to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","BK1583","LU0348827113.USD","LU0348783233.USD","LU0417516571.SGD","LU0348825331.USD","BK1587","LU1720050803.USD","LU0348784397.USD","LU0417516902.SGD","LU0634319403.HKD","LU2476274308.USD","MEDX","BK1161","LU0417516738.SGD","LU2399975544.HKD","LU2476274720.SGD","BK1574","02162","159992","LU2778985437.USD","LU2488822045.USD","LU0348766576.USD","IE00B5MMRT66.SGD","09926","LU0540923850.HKD","IE00BPRC5H50.USD","LU1961090484.USD","IE00B543WZ88.USD","LU0348767384.USD","LU0348735423.USD","KURE","LU1794554557.SGD","06978","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192984128","title":"Shares of TRANSCENTA-B Surge Over 29% Intraday After Chairman Qian Xueming Increases Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=1192984128","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192984128?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:40","pubTimestamp":1789962029,"startTime":"0","endTime":"0","summary":"Shares of TRANSCENTA-B (06628) surged more than 29% during morning trading before paring gains to trade 21.54% higher at HK$1.185, with turnover reaching HK$5.2075 million.According to the latest...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","06628","159938","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176612965","title":"Hong Kong Stock Alert | METIS TECHBIO-P (07666) Surges Over 9% Again, AI Drug Development Momentum Builds on Multiple Catalysts — Company's AI Plus Delivery Platform Value Gaining Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=1176612965","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176612965?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:14","pubTimestamp":1789956855,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (07666) climbed more than 9% in early Hong Kong trading, extending a rally that has pushed the stock up over 35% across the past three sessions. At the time of writing, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AIPO","07666","BK1161","BK4585","ARTY","VXUS","BK1191","CHAT","BK1574","AGIX","VTHR","01477","KCAI","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110824153","title":"Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1110824153","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110824153?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:10","pubTimestamp":1789956642,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 6% in Hong Kong trading, last up 6.58% to HK$5.83 with turnover reaching HK$192 million.According to a research note from Daiwa, at a recent healthcare...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","HK0000165453.HKD","BK1589","VXUS","01177","IE00BZ08YS42.EUR","06978","BK1191","BK1515","LNGR","BK4588","BK1574","BK1521","IE00BZ08YT58.USD","KCAI","IBBQ","IE00BZ08YR35.GBP","BK1161","BK4585","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194533771","title":"Hong Kong Stock Market Flash | Genscript Biotech Surges Over 7% in Morning Session as AI Drug Discovery Models Reshape Its Business Trajectory","url":"https://stock-news.laohu8.com/highlight/detail?id=1194533771","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194533771?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:08","pubTimestamp":1789956499,"startTime":"0","endTime":"0","summary":"Shares of Genscript Biotech (01548) rallied more than 7% during the morning trading session in Hong Kong. At the time of writing, the stock was up 6.56%, trading at HK$41.92 with turnover reaching...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LRNZ","BK1191","AGIX","HK0000306685.HKD","VXUS","HK0000306701.USD","BK1141","AIPO","VTHR","01548","BK1574","KCAI","ARTY","GPTZ","QTOC","BK4588","BK1583","WISE","01477","HK0000320223.HKD","BK4585","CHAT","HK0000320264.USD","EPAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151998019","title":"Beyond 2025: How AI Drug Discovery Companies Will Be Priced on Speed, Depth, and Modality Optionality","url":"https://stock-news.laohu8.com/highlight/detail?id=1151998019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151998019?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:38","pubTimestamp":1789954719,"startTime":"0","endTime":"0","summary":"On September 18th, ten government departments including the Ministry of Industry and Information Technology released the “15th Five-Year Plan” for the pharmaceutical industry. The policy framework...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","AIPO","CHAT","ARTY","01477","QTOC","02228","BK1191","AGIX","BK1617","BK1574","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145613107","title":"本周科技板块亮点密集，AI制药成市场新焦点｜港股策略前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=1145613107","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145613107?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:10","pubTimestamp":1789953032,"startTime":"0","endTime":"0","summary":"【市场综述】美联储加息靴子落地，尽管基调偏鹰，但港股上周探底回升，整体表现优于预期。中东方面，美伊关系出现缓和迹象，伊方表示已获调解方告知，美国正以“认真态度”准备与其谈判并达成协议，目前等待特朗普政府回应。不过仍需警惕美方对胡塞武装采取行动，可能招致其报复性打击沙特。中美经贸预期升温，中方将于9月19日至23日率团赴美进行经贸磋商，新一轮对话有望缓解双边贸易紧张局势，并支撑人民币汇率走强。综合来...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","QTOC","00699","AGIX","BK1191","BK1144","02050","AIPO","ARTY","BK1574","SG9999011746.SGD","01477","BK1183","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669332801","title":"Antengene Doses First Patient in Phase III Clinch-3 Trial of ATG-022 for Cldn18.2+ Gastric, GEJ Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669332801","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669332801?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:30","pubTimestamp":1789950623,"startTime":"0","endTime":"0","summary":"Antengene doses first patient in Phase III CLINCH-3 trial of ATG-022 for CLDN18.2+ gastric, GEJ cancerAntengene dosed the first patient in China in the pivotal Phase III CLINCH-3 trial of ATG-022 for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL2rgfTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","06996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193243078","title":"GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1193243078","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193243078?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:30","pubTimestamp":1789950614,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 18, a significant position shift was observed in GENFLEET-B (02595), with the total market value of the transferred shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595","09939","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669281133","title":"Antengene Announces First Patient Dosed in Pivotal Phase Iii Clinch-3 Study of Atg-022","url":"https://stock-news.laohu8.com/highlight/detail?id=2669281133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669281133?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:30","pubTimestamp":1789950600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUAQF3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1583","BK1574","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108446847","title":"GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18","url":"https://stock-news.laohu8.com/highlight/detail?id=1108446847","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108446847?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:28","pubTimestamp":1789950501,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has disclosed that, as of September 18, 2026, the company executed a series of H-share repurchases on The Stock Exchange of Hong Kong Limited, accumulating a total of 872,000...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","159938","02595","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195096364","title":"Australian Drug Maker Telix Strikes $1.65B Deal for Germany's ITM","url":"https://stock-news.laohu8.com/highlight/detail?id=1195096364","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195096364?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:10","pubTimestamp":1789949423,"startTime":"0","endTime":"0","summary":"Australian biotech Telix Pharmaceuticals announced on Monday that it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for approximately $1.65 billion, based on a cash-free,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDXSmain","BK1574","FDXMmain","BK1191","FDAXmain","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120731445","title":"China Securities: Small-Cap Growth Outperforms While Healthcare Funds Show Strong Weekly Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1120731445","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120731445?lang=en_us&edition=fundamental","pubTime":"2026-09-21 07:51","pubTimestamp":1789948280,"startTime":"0","endTime":"0","summary":"China Securities has released its latest research report indicating that during the trading week of September 14-18, the CSI 300 Index dipped 0.06% while the Hang Seng Tech Index climbed 1.97%, with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","601066","159938","BK0276","BK1515","399376"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131150402","title":"AI-Driven Drug Development Hits a Milestone Phase as New Policies Fuel Momentum—Which ETF Offers the Highest AI Exposure?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131150402","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131150402?lang=en_us&edition=fundamental","pubTime":"2026-09-20 19:10","pubTimestamp":1789902639,"startTime":"0","endTime":"0","summary":"On September 18, A-share and Hong Kong-listed healthcare stocks continued their upward trajectory, with AI-driven drug development leading the charge. The Hong Kong Stock Connect Healthcare Thematic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","VTHR","QTOC","AIPO","01477","FDN","ARTY","BK4585","CHAT","BK4550","AGIX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194876333","title":"H Share Subscription Deal Between TYK Medicines and Qilu Expires","url":"https://stock-news.laohu8.com/highlight/detail?id=1194876333","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194876333?lang=en_us&edition=fundamental","pubTime":"2026-09-20 19:10","pubTimestamp":1789902618,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that its share subscription agreement with Qilu, linked to a licensing and collaboration deal, has lapsed. The agreement concerned the proposed issue of 63.22...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02410","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190333736","title":"Yan'an Pharma Withdraws Beijing IPO for Second Time, Sees Nearly Doubled Fundraising Target Questioned","url":"https://stock-news.laohu8.com/highlight/detail?id=1190333736","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190333736?lang=en_us&edition=fundamental","pubTime":"2026-09-20 16:50","pubTimestamp":1789894229,"startTime":"0","endTime":"0","summary":"Beijing Stock Exchange recently disclosed a termination review notice, confirming that Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd., referred to as Yan'an Pharma, has again withdrawn its listing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","REDS","BK1161","KCE","FRHC","IPOS","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166262684","title":"From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?","url":"https://stock-news.laohu8.com/highlight/detail?id=1166262684","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166262684?lang=en_us&edition=fundamental","pubTime":"2026-09-20 13:40","pubTimestamp":1789882836,"startTime":"0","endTime":"0","summary":"For a long stretch, innovative drug companies left investors with an impression of \"burning cash for stories.\" Huge R&D spending, commercialization that seemed perpetually distant, and valuations...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","MEDX","06978","LNGR","BK1574","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132217826","title":"Money Xue Purchases Additional Trancenta Shares at HK$0.8552 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1132217826","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132217826?lang=en_us&edition=fundamental","pubTime":"2026-09-20 10:11","pubTimestamp":1789870261,"startTime":"0","endTime":"0","summary":"A recent disclosure from the Hong Kong Stock Exchange reveals that on September 17, Xue Ming acquired 100,000 shares of TRANSCENTA-B (06628). The transaction was executed at a price of HK$0.8552 per...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1515","EWH","09939","159938","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116395342","title":"BRII-B (02137) Spends HK$25,800 on Share Buyback on September 18","url":"https://stock-news.laohu8.com/highlight/detail?id=1116395342","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116395342?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:14","pubTimestamp":1789733654,"startTime":"0","endTime":"0","summary":"BRII-B (02137) announced that on September 18, 2026, it utilized HK$25,800 to repurchase 30,000 of its shares.This buyback reflects the company's ongoing capital management strategy, as it continues to invest in its own stock amid market conditions.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157650345","title":"Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1157650345","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157650345?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:58","pubTimestamp":1789732702,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has officially announced that its controlling subsidiaries, Jiangxi Tellgen Life Science Technology Co., Ltd. and Shanghai Maishi Biotechnology Co., Ltd., have...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","MDEV","BK1100","159883","IEIH","GDOC","300642","LGHT","BK1583","RSPH","MEDX","BK0046","PTH","BK0042","BK0239","BK1574","HART","LNGR","AGNG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":199,"code":"91000000","status":"200"}]}}